AI assistant
Cryoport, Inc. — Director's Dealing 2021
Dec 15, 2021
32876_dirs_2021-12-15_ef0c1821-4f89-48f8-9694-75b55d8abd8d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2021-12-10
Reporting Person: SHELTON JERRELL (Director, President, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-10 | Common Stock | M | 26418 | $2.40 | Acquired | 590510 | Direct |
| 2021-12-10 | Common Stock | M | 38545 | $3.24 | Acquired | 629055 | Direct |
| 2021-12-10 | Common Stock | S | 16427 | $64.9418 | Disposed | 612628 | Direct |
| 2021-12-10 | Common Stock | S | 8710 | $65.5663 | Disposed | 603918 | Direct |
| 2021-12-10 | Common Stock | S | 1281 | $66.8935 | Disposed | 602637 | Direct |
| 2021-12-10 | Common Stock | S | 29144 | $64.8861 | Disposed | 573493 | Direct |
| 2021-12-10 | Common Stock | S | 8092 | $65.5376 | Disposed | 565401 | Direct |
| 2021-12-10 | Common Stock | S | 1309 | $66.8698 | Disposed | 564092 | Direct |
| 2021-12-13 | Common Stock | M | 287 | $3.24 | Acquired | 564379 | Direct |
| 2021-12-13 | Common Stock | S | 200 | $64.8650 | Disposed | 564179 | Direct |
| 2021-12-13 | Common Stock | S | 87 | $65.84 | Disposed | 564092 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-10 | Option to purchase common stock | $2.40 | M | 26418 | Disposed | 2022-11-05 | Common Stock (26418) | Direct |
| 2021-12-10 | Option to purchase common stock | $3.24 | M | 38545 | Disposed | 2023-06-28 | Common Stock (38545) | Direct |
| 2021-12-13 | Option to purchase common stock | $3.24 | M | 287 | Disposed | 2023-06-28 | Common Stock (287) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $65.34, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.36 to $66.23, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.72 to $67.57, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $65.35, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.36 to $66.35, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.72 to $67.6950, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.55 to $65.18, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9: 1/12 of the options vested on the 22nd of each month for twelve months beginning on 11/22/2012 and ending on 10/22/2013.
F10: 1/6 of the options vested on the 5th of each month for six months beginning on 12/5/2012 and ending on 5/5/2013.
F11: 1/24 of the options vested immediately and 1/46 of the remaining options vested on the 5th of each month for forty six months beginning on 7/5/2013 and ending on 5/5/2017.